Scientists have uncovered a significant clue to understanding why some individuals are more susceptible to Alzheimer’s disease.
A new study has found that genetic predispositions for neuroticism may predict the onset of Alzheimer's in individuals with amnestic mild cognitive impairment.
Higher cognitive reserve improves cognitive functioning in older adults, but stress, indicated by cortisol levels, reduces this benefit. The study highlights the interplay between cognitive reserve, stress, and Alzheimer's biomarkers.
Scientists found that genes related to immune activity may help some people resist Alzheimer’s symptoms, even with high amyloid levels, highlighting lifestyle and genetic factors in disease resilience.
Researchers developed an AI model that predicts Alzheimer's progression with 78.5% accuracy by analyzing speech patterns from neuropsychological tests, offering a non-invasive early detection method.
Type 2 diabetes patients treated with GLP-1 agonists, like Ozempic, have a reduced risk of developing dementia compared to those on older diabetes medications, according to a new study.
Intensive lifestyle changes, including a plant-based diet, exercise, stress management, and social support, improved cognitive function and daily living activities in patients with mild cognitive impairment or early dementia due to Alzheimer's disease.
A German study found that combining personality traits, depression, anxiety scores, and cerebrospinal fluid biomarkers aids in predicting Alzheimer's disease.
A recent study found that higher amyloid-beta levels in the brain are linked to faster volume loss in the basal forebrain and hippocampus, even before cognitive symptoms of Alzheimer’s disease appear.
New research suggests menthol inhalation may improve cognitive abilities in mice with Alzheimer’s by regulating the immune system and reducing brain inflammation, offering a potential new avenue for treating this debilitating disease.
Combining Alzheimer's drugs Donepezil and Memantine significantly extends patients' lives, offering new hope for improved treatment and survival.
Researchers discovered a genetic variant that reduces Alzheimer's disease risk by up to 70%, aiding in the removal of toxic amyloid from the brain. This highlights the role of the brain's blood vessels and suggests new therapeutic approaches.
Researchers have discovered that the brain protein Mfsd7c plays a crucial role in exporting excess choline, challenging previous beliefs and opening new possibilities for treating Alzheimer’s disease and age-related cognitive decline.
Researchers found that reduced connectivity between the locus coeruleus and medial temporal lobe in cognitively healthy individuals is linked to faster brain atrophy and cognitive decline, particularly in the presence of amyloid beta, suggesting early markers for Alzheimer's disease progression.
A high-fat diet leads to metabolic deterioration and significant changes in specific microRNAs, according to new research, which are associated with the pathological processes of Alzheimer's disease.